IL276008A - Antibodies that increase factor h activity and their uses - Google Patents

Antibodies that increase factor h activity and their uses

Info

Publication number
IL276008A
IL276008A IL276008A IL27600820A IL276008A IL 276008 A IL276008 A IL 276008A IL 276008 A IL276008 A IL 276008A IL 27600820 A IL27600820 A IL 27600820A IL 276008 A IL276008 A IL 276008A
Authority
IL
Israel
Prior art keywords
factor
potentiating antibodies
potentiating
antibodies
Prior art date
Application number
IL276008A
Other languages
English (en)
Hebrew (he)
Inventor
Willem Kuijpers Taco
Wouters Diana
Clara Brouwer Maria
Benjamin Pouw Richard
Original Assignee
Stichting Sanquin Bloedvoorziening
Willem Kuijpers Taco
Wouters Diana
Clara Brouwer Maria
Benjamin Pouw Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin Bloedvoorziening, Willem Kuijpers Taco, Wouters Diana, Clara Brouwer Maria, Benjamin Pouw Richard filed Critical Stichting Sanquin Bloedvoorziening
Publication of IL276008A publication Critical patent/IL276008A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL276008A 2018-01-15 2020-07-13 Antibodies that increase factor h activity and their uses IL276008A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18151726 2018-01-15
PCT/NL2019/050018 WO2019139481A1 (en) 2018-01-15 2019-01-15 Factor h potentiating antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL276008A true IL276008A (en) 2020-08-31

Family

ID=60972152

Family Applications (1)

Application Number Title Priority Date Filing Date
IL276008A IL276008A (en) 2018-01-15 2020-07-13 Antibodies that increase factor h activity and their uses

Country Status (11)

Country Link
US (2) US11377487B2 (enExample)
EP (1) EP3740502A1 (enExample)
JP (2) JP7471224B2 (enExample)
KR (2) KR102896085B1 (enExample)
CN (1) CN111868083B (enExample)
AU (1) AU2019206207B2 (enExample)
BR (1) BR112020014399A2 (enExample)
CA (1) CA3088507A1 (enExample)
IL (1) IL276008A (enExample)
MX (1) MX2020007555A (enExample)
WO (1) WO2019139481A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020014399A2 (pt) * 2018-01-15 2020-12-29 Stichting Sanquin Bloedvoorziening Anticorpos potenciadores do fator h e seus usos
BR112022000739A2 (pt) * 2019-07-17 2022-04-12 Gemini Therapeutics Sub Inc Anticorpos de potencialização de fator h e usos dos mesmos
CN114560941B (zh) * 2020-11-27 2024-01-16 广东东阳光药业股份有限公司 Cldn18.2的抗体及其应用
MX2024001301A (es) * 2021-07-30 2024-04-18 Scherer Technologies Llc R P Anticuerpos y conjugados de anticuerpo especificos para nectina 4 y metodos de uso de los mismos.
CN116041521B (zh) * 2022-03-21 2023-11-03 南京蓬勃生物科技有限公司 靶向Siglec-15的单克隆抗体及其应用
NL2032398B1 (en) * 2022-07-06 2024-01-23 Academisch Ziekenhuis Leiden Bispecific antibody and uses thereof
CN118878671B (zh) * 2024-07-04 2025-09-30 南京农业大学 抗兽疫链球菌SzM蛋白的猪源化单克隆抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013508287A (ja) * 2009-10-14 2013-03-07 ヤンセン バイオテツク，インコーポレーテツド 抗体を親和性成熟する方法
WO2011056997A1 (en) * 2009-11-04 2011-05-12 Fabrus Llc Methods for affinity maturation-based antibody optimization
KR102709811B1 (ko) * 2014-08-20 2024-09-24 스티흐팅 산퀸 불드포르지닝 인자 h 강화 항체 및 그의 용도
US10316093B2 (en) * 2014-08-27 2019-06-11 Memorial Sloan Kettering Cancer Center Antibodies, compositions, and uses
BR112020014399A2 (pt) * 2018-01-15 2020-12-29 Stichting Sanquin Bloedvoorziening Anticorpos potenciadores do fator h e seus usos
BR112022000739A2 (pt) * 2019-07-17 2022-04-12 Gemini Therapeutics Sub Inc Anticorpos de potencialização de fator h e usos dos mesmos

Also Published As

Publication number Publication date
CA3088507A1 (en) 2019-07-18
JP2021510523A (ja) 2021-04-30
JP2023089191A (ja) 2023-06-27
BR112020014399A2 (pt) 2020-12-29
CN111868083B (zh) 2025-02-11
US11377487B2 (en) 2022-07-05
US20220356235A1 (en) 2022-11-10
US20210054059A1 (en) 2021-02-25
KR20250171487A (ko) 2025-12-08
KR20200110688A (ko) 2020-09-24
EP3740502A1 (en) 2020-11-25
KR102896085B1 (ko) 2025-12-08
JP7471224B2 (ja) 2024-04-19
MX2020007555A (es) 2021-01-15
WO2019139481A1 (en) 2019-07-18
AU2019206207A1 (en) 2020-08-13
AU2019206207B2 (en) 2025-04-10
CN111868083A (zh) 2020-10-30

Similar Documents

Publication Publication Date Title
IL276950B1 (en) Anti-CD73 antibodies and their uses
IL282968A (en) Anti-NKG2A antibodies and their use
SG11202105885WA (en) Anti-claudin antibodies and uses thereof
ZA202006904B (en) Anti-il-4r antibody and use thereof
IL275826A (en) Anti-mct1 antibodies and their uses
ZA202006066B (en) Anti-hla-g antibodies and use thereof
SG11202104240TA (en) Cll1-targeting antibody and application thereof
IL289585A (en) DLL3-targeted antibodies and uses thereof
IL276008A (en) Antibodies that increase factor h activity and their uses
SG11202009772PA (en) Anti-dll3 antibodies and uses thereof
IL281202A (en) Anti-TNFRSF9 antibodies and uses thereof
ZA202100714B (en) Anti-npr1 antibodies and uses thereof
IL280321A (en) Antibodies against CXCR2 and their uses
IL291027A (en) Anti-steap1 antibodies and uses thereof
IL277075A (en) Anti-PHF-tau antibodies and uses thereof
SG11202009625WA (en) Anti-trem-1 antibodies and uses thereof
SG11202112112UA (en) Anti-galectin-9 antibodies and uses thereof
IL282707A (en) Anti-tim-3 antibodies and their use
IL282708A (en) Anti-tim-3 antibodies and their use
IL283875A (en) Anti-il-27 antibodies and uses thereof
IL277330A (en) Anti-IL-27 antibodies and uses thereof
SG11202012680TA (en) Anti-l1cam antibodies and uses thereof
IL276548A (en) Binding antibodies - BCMA and their uses
IL283890A (en) Anti-periostin antibodies and their uses
IL291546A (en) Antibodies against kir3dl3 and their uses